SAMRAT PHARMACHEM
Back to All Ratios
|
SAMRAT PHARMACHEM Last 5 Year Return on Capital Employed (ROCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 13.61 | 4.13 | 34.91 | 52.33 | 23.90 |
What is the latest Return on Capital Employed (ROCE) ratio of SAMRAT PHARMACHEM ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 13.61 |
| Mar2024 | 4.13 |
| Mar2023 | 34.91 |
| Mar2022 | 52.33 |
| Mar2021 | 23.90 |
How is Return on Capital Employed (ROCE) of SAMRAT PHARMACHEM Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 13.61 | 229.54 | |
| Mar2024 | 4.13 | -88.17 | |
| Mar2023 | 34.91 | -33.29 | |
| Mar2022 | 52.33 | 118.95 | |
| Mar2021 | 23.9 | - | |
Other Financial Ratios of SAMRAT PHARMACHEM
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹63.0 Cr | -3% | -7% | -42.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -3% |
-7% |
-42.2% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses